Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cell & Gene Therapy Drug Delivery Devices Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of chronic and genetic disorders
5.1.1.2. Growing number of drug approvals for treatment of cellular and genetic disorders
5.1.1.3. Increasing number of clinical trials and medical treatments requiring advanced drug delivery systems
5.1.2. Restraints
5.1.2.1. High cost of drug delivery devices
5.1.3. Opportunities
5.1.3.1. Advancements in nanotechnology and development of biomaterials
5.1.3.2. Utilization of AI, ML, and sensor technologies for drug delivery
5.1.4. Challenges
5.1.4.1. Complex regulatory challenges of genetic therapies and difficulties with approval of medical devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cell & Gene Therapy Drug Delivery Devices Market, by Products
6.1. Introduction
6.2. Extension Tube
6.3. Infusion Bags
6.4. Intravenous Catheter
6.5. Pre-Filled Syringe
6.6. Sterile Insulin Syringe
6.7. Subretinal Injection Cannula

7. Cell & Gene Therapy Drug Delivery Devices Market, by Commercialized Drugs
7.1. Introduction
7.2. Kymriah
7.3. Luxturna
7.4. Provenge
7.5. Strimvelis
7.6. Yescarta
7.7. Zolgensma

8. Americas Cell & Gene Therapy Drug Delivery Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cell & Gene Therapy Drug Delivery Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cell & Gene Therapy Drug Delivery Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Amgen Inc.
12.1.2. Bausch & Lomb Incorporated
12.1.3. Becton, Dickinson and Company
12.1.4. Bluebird bio, Inc.
12.1.5. Castle Creek Biosciences, Inc. by Paragon Biosciences, LLC
12.1.6. Dendreon Pharmaceuticals LLC.
12.1.7. Helixmith Co., Ltd.
12.1.8. Kite Pharma, Inc. by Gilead
12.1.9. Kolon TissueGene, Inc.
12.1.10. Novartis AG
12.1.11. Orchard Therapeutics
12.1.12. Pfizer, Inc.
12.1.13. Renova Therapeutics
12.1.14. Spark Therapeutics, Inc.
12.1.15. uniQure N.V.
12.1.16. Vericel Corporation
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET DYNAMICS
FIGURE 7. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 8. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2023 VS 2030 (%)
FIGURE 10. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 6. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY EXTENSION TUBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY STERILE INSULIN SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY SUBRETINAL INJECTION CANNULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 13. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY KYMRIAH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY LUXTURNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PROVENGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY STRIMVELIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY YESCARTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY ZOLGENSMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 26. CANADA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 27. CANADA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 28. MEXICO CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 29. MEXICO CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 37. AUSTRALIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 38. CHINA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 39. CHINA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 40. INDIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 41. INDIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 43. INDONESIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 44. JAPAN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 45. JAPAN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 47. MALAYSIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. PHILIPPINES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 51. SINGAPORE CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. SOUTH KOREA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 55. TAIWAN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 56. THAILAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 57. THAILAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. VIETNAM CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. DENMARK CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 64. DENMARK CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 65. EGYPT CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 66. EGYPT CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 67. FINLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 68. FINLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 69. FRANCE CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 70. FRANCE CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 71. GERMANY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 72. GERMANY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 74. ISRAEL CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 75. ITALY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. ITALY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. NETHERLANDS CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 80. NIGERIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 81. NORWAY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. NORWAY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 83. POLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 84. POLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 85. QATAR CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. QATAR CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 88. RUSSIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 94. SPAIN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. SWEDEN CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 98. SWITZERLAND CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 99. TURKEY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 100. TURKEY CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SIZE, BY COMMERCIALIZED DRUGS, 2018-2030 (USD MILLION)
TABLE 105. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 106. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 107. CELL & GENE THERAPY DRUG DELIVERY DEVICES MARKET LICENSE & PRICING